Sonio

About Sonio

Sonio, a wholly-owned subsidiary of Samsung Medison Co., Ltd since 2024, is a highly customizable workflow and practice management solution powered by AI for automation, efficiency, and quality control. Sonio AI-enhanced software empowers ultrasound practitioners and readers. Sonio assists them in performing every prenatal examination to their highest quality standards, ensuring the completeness of each examination, streamlining their workflow, and in prenatal diagnosis. Sonio is based on over five years of research and collaboration between leading experts in fetal medicine and AI. AI-enhancement is provided by FDA 510(k) cleared Sonio Detect product. Applicable to V1 only, Data enclosed at Sonio. See table 6 in the 510k summary.